Register now for Wednesday's AI Clinic, "Je m'appelle Claude: Thinking, Prompting, & Building with LLMs," presented by our EIPM colleague Alex Sigaras!

Congrats to Dr. Juan Miguel Mosquera from WCM's Pathology and WCM's EIPM, with Dr. Eda Nur Kozan from WCM Pathology, on "Whole Genome Sequencing of Locally Advanced and Metastatic Breast Carcinoma Unravels Relevant Molecular Signatures and Novel Events." www.sciencedirect.com/science/arti...

Please join us (virtually) tomorrow at noon for another EIPM Precision Medicine Seminar, "Single-cell Spatial Omics Journey to Signaling and Metabolism of Immunity, Cancer & Aging," presented by Dr. Ahmet Coskun (@ahmetfcoskun) from
@GeorgiaTech and @EmoryUniversity!

Just scheduled!

The next @WCMEnglanderIPM #PrecisionMedicine #AI Working Group, "A Foundation Model Augmented Polygenic Risk Score for Neural Tube Defects," will be presented by #neuroscientist Dr. Alokkumar Jha next Friday at 11 am.

Register today!

"Cancer is uniquely positioned to benefit from AI because we now have massive datasets spanning genomics, imaging and clinical outcomes that AI can finally put to use," said EIPM Director Olivier Elemento, Ph.D. (@ElementoLab)!

Learn more:
eipm.weill.cornell.edu/news/wcm-inv...

Join 100+ Cornell faculty and staff, including EIPM Director Olivier Elemento, PhD (@ElementoLab) for Cornell's "Artificial Intelligence for Basic Research in Medicine and the Life Sciences," June 1-2 in New York City!

Register today: www.cognitoforms.com/IPM3/Symposi...

Calling all Weill Cornell Medicine, Cornell University & Cornell Tech faculty & staff:

Don't miss the Artificial Intelligence (#AI) for Basic Research in Medicine and the Life Sciences Symposium on June 1-2!

Space limited, registration required by May 8:
www.cognitoforms.com/IPM3/Symposi...

Please join us in congratulating our Chief Research Officer Dr. Bishoy Faltas on earning a $1 million Research Scholar Grant from the American Cancer Society to develop new therapy combinations for hard-to-treat urinary tract cancers!

eipm.weill.cornell.edu/news/america...

AI May Soon Detect Cancer Just by Listening to You Speak New research explores how hidden patterns in the human voice could serve as early indicators of disease.

Really interesting new article in SciTechDaily, "AI May Soon Detect Cancer Just by Listening to You Speak," about the Bridge2AI-Voice’ project that the EIPM help create!

scitechdaily.com/ai-may-soon-...

Be sure to put this one on your calendar.....

There is still time to register for today's EIPM Seminar!

New @JCO_ASCO paper by our Clinical Director Dr. Cora N. Sternberg (@cnsternberg), "Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide.

ascopubs.org/doi/10.1200/...

Register today for our next #AI Clinic, led by EIPM Member Dr. Iman Hajirasouliha (@hajirasouliha), on "Using #LLMs and #AI Paper-Review Tools to Revise Scientific Manuscripts: A Case Study on Generating Synthetic Human #Blastocyst Images," on March 25th!

Many of health care’s toughest challenges are waiting for creative solutions. At the Cornell Health AI Hackathon, organized by Entrepreneurship at Cornell, with partners including the EIPM, student teams spent an intense weekend racing to build some of them!

news.weill.cornell.edu/news/2026/03...

The Cornell Health AI Hackathon Showed Me What the Future of Healthcare Could Look Like Last week, I had the privilege of helping organize the Cornell Health AI Hackathon, a week that built steadily from team formation to technical preparation, from kickoff to workshops, and from intense...

Check out the new article, "The Cornell Health AI Hackathon Showed Me What the Future of Healthcare Could Look Like," by our EIPM colleague Alex Sigaras (@AlexSigaras), Ass't Prof. of Research in Systems and Computational Biomedicine at Weill Cornell Medicine!

www.linkedin.com/pulse/cornel...

Registered today for the next Cyma Rubin Women in Science Lectureship, "From Pathways to People: Building a Career in Precision Medicine," featuring Dr. Svati H. Shah from the Duke University School of Medicine and hosted by WCM Dean Robert Harrington & Cyma Rubin!

Register now for Friday's #PrecisionMedicine #AI Working Group where Dr. Narges Razavian (@narges_razavian) will present, "Agentic and Foundational #AI in Healthcare--Obstacles, Opportunities, and a Vision for the Near Future!"

Register today for the next EIPM Precision Medicine Research Conference featuring talks by our colleague Dr. Eda Nur Kozan and Dr. Jesus Delgado De La Mora from the Pathology and Laboratory Medicine department, on March 19th at 1 pm!

Dual-positive CTCs in patients with advanced breast cancer show metastatic potential and prognostic value Dual-positive CTCs are prognostic in patients with advanced breast cancer, have aberrant genomes, and, in vivo, can form metastasis.

Congratulations to our Scientific Director Dr. Massimo Cristofanilli & Dr. Carolina Reduzzi on their new Science Translational Medicine paper, "Dual-positive #CTCs in patients with advanced breast cancer show metastatic potential and prognostic value."

www.science.org/doi/10.1126/...

Be sure to register today for the next Cyma Rubin Women in Science Lectureship, "From Pathways to People: Building a Career in Precision Medicine," featuring Dr. Svati H. Shah from
@DukeMedSchool and hosted by WCM Dean Robert Harrington & Cyma Rubin!

weillcornell.az1.qualtrics.com/jfe/form/SV_...

A Conversation with Benjamin D. Hopkins, Ph.D., EIPM's Director of Ex Vivo Models. YouTube video by Englander Institute for Precision Medicine WCM

We hope you enjoy "A Conversation with Dr. Benjamin Hopkins," (@Degreesofhealth) EIPM's Director of Ex Vivo Models, on #organoids #colorectal cancer #ovariancancer #immunology #breastcancer and improving immune responses in patients!

youtu.be/C5DEuXVMTSU

A study in Nature Communications Identifies Gene Linked to Chemotherapy Resistance in Prostate Cancer.

"The research opens the door to developing therapies that could block the resistance and restore drug effectiveness.” said EIPM's Dr. Paraskevi Giannakakou.

news.weill.cornell.edu/news/2026/03...

Molecular Landscape of Prostate Cancers with Clival Metastases AbstractBackground. Clival metastases are a rare and clinically aggressive manifestation of advanced prostate cancer, associated with cranial nerve palsy a

Congratulations to our Clinical Director Cora N. Sternberg, M.D. on her new paper in The Oncologist, "Molecular Landscape of Prostate Cancers with Clival Metastases."

academic.oup.com/oncolo/advan...

Please join us Wednesday!

Congrats to our EIPM colleague Dr. Ekta Khurana (@ekta_khurana) on earning a $1 million Award from the Prostate Cancer Foundation (@PCFnews) to develop an #AI-based method for early detection of treatment-resistant #prostatecancer!

eipm.weill.cornell.edu/news/eipm-re...

Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4 PURPOSEThe continuous development of new imaging approaches, molecular phenotyping, genetic subtypes, prognosis assessments, and effective therapies across a range of disease states has created a need...

We have a new Journal of Clinical Oncology paper, "Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4," just published by EIPM Clinical Director Dr. Cora N. Sternberg and colleague Dr. Scott Tagawa!

ascopubs.org/doi/pdf/10.1...

Identification of Protein Signatures Reflecting Latent Variation in Aptamer-Based Affinity Proteomics Accurate quantification of circulating proteins is critical for assessing biological variation and integrating proteomics with other omics to understand biological processes and disease mechanisms. Protein measurements, however, can be substantially influenced by preanalytical variability arising from differences in sample collection, handling, and storage, whereas technical variation introduced by the assay and workflow is typically well controlled through established validation procedures. Identifying proteins that capture these systematic influences enables their incorporation into downstream analyzes, thereby improving statistical power. In this study, we applied highly multiplexed aptamer-based affinity proteomics to plasma samples from three independent cohorts─German, Arab-Asian and Qatari to evaluate how adjusting for all measured proteins influences protein quantitative trait loci (pQTLs) associations. Using the p-gain statistic as an indicator of improved association strength, we identified clusters of proteins whose covariation patterns suggested potential preanalytical effects. One cluster contained HSP90 (Heat Shock Protein 90), a marker linked to white blood cell lysis, while others were enriched for proteins involved in complement and coagulation cascades or platelet activation. Our work presents a data-driven framework for detecting latent sources of variation in large-scale proteomic data sets and lay the groundwork for future efforts to quantify the impact of hidden confounding factors.

Check out the new Journal of Proteome Research (@ACSPublications) paper, "Identification of Protein Signatures Reflecting Latent Variation in Aptamer-Based Affinity Proteomics," by EIPM's Dr. Karsten Suhre!

pubs.acs.org/doi/10.1021/...

Utilization of Serum Metabolomics and Polygenic Risk Scores in a Novel Risk Stratification Tool for the Prediction of Incident Atrial Fibrillation | Circulation: Arrhythmia and Electrophysiology BACKGROUND: Atrial fibrillation (AF) is associated with substantial morbidity and mortality. We sought to investigate the predictive value of serum metabolomics for 5-year incident AF in the context o...

New paper, "Utilization of Serum Metabolomics and Polygenic Risk Scores in a Novel Risk Stratification Tool for the Prediction of Incident Atrial Fibrillation," in Circulation: Arrhythmia and Electrophysiology by EIPM Drs. Olivier Elemento and Jan Krumsiek!

www.ahajournals.org/doi/10.1161/...

Register today to attend the next MCC Cancer Biology Research Program meeting featuring EIPM's Dr. Vivek Mittal presenting "Epigenetic, Metabolic, and Immune Drivers of Breast Cancer Metastasis," this Friday at noon in Belfer 302-A/B.

Register: weillcornell.az1.qualtrics.com/jfe/form/SV_...

International Day of Women & Girls in Science is a great opportunity to showcase the important work we do to educate young women through our summer internship #InternationalDayOfWomenAndGirlsInScience
eipm.weill.cornell.edu/education/st...